Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Update on 2-DTech Ltd

4 Nov 2014 07:00

RNS Number : 0436W
Versarien PLC
04 November 2014
 

 

 

 

Press Release

4 November 2014

 

 

Versarien plc

("Versarien" or the "Group")

 

Update on 2-DTech Ltd

 

Versarien Plc (AIM:VRS), the advanced engineering materials group, is pleased to provide the following commercial update on 2-DTech Ltd ("2-DTech" or the "company"), the Group's graphene application and product development subsidiary which was acquired in May 2014.

 

Versarien also announces that 2-DTech will be hosting a site visit in Manchester for institutional investors, analysts and media on 19 November 2014. The site visit will enable the company to demonstrate the progress made since May in the commercialisation of graphene and will include a tour of the 2-DTech facility and presentations by leaders in this technology from 2-DTech and the University of Manchester.

 

In line with Versarien's strategy of supporting the road to product commercialisation through technology finance, 2-DTech has been awarded two separate grants from InnovateUK, formerly known as the Technology Strategy Board.

 

2-DTech will receive £80,000 for a collaborative project with Evodental, a leading dental implant company, to produce graphene-reinforced polymers for fixed dental prostheses.

 

• 2-DTech will receive £98,000 to explore the functionalisation of solid-state dye-sensitised solar cells which will be expedited in conjunction with Dyesol Ltd, the Australian solar clean tech company.

 

The InnovateUK grants supplement the existing £240,000 University of Manchester proof of concept grant for the commercialisation of a unique production process for which Versarien has now filed its first patent, jointly with the University of Ulster.

 

As a result of 2-DTech's progress and to strengthen the company's relationship with University of Manchester it has further strengthened the management team through two new senior appointments.

 

Dr. Aravind Vijayaraghaven, who is a lecturer in Nanomaterials at the University of Manchester, and is the public engagement coordinator for the National Graphene Institute, has joined 2-DTech as a Senior Consultant. The Board believes that Dr. Vijayaraghaven's reputation in the industry of nanomaterials and in the field of graphene will be of significant benefit to 2-DTech as it embarks on a number of planned collaboration projects.

 

2-DTech has also appointed Dr. Andrew Strudwick as a Research Scientist. Dr. Strudwick completed his PhD in the condensed matter physics department at the University of Leeds before working for BASF on commercialising graphene projects.

 

Neill Ricketts, Chief Executive Officer of Versarien, commented: "Since the acquisition in May, 2-DTech has made excellent progress with many of our key objectives being achieved well ahead of schedule whilst still keeping a strict control over costs. The two InnovateUK grants are testament to the hard work by 2-DTech and demonstrate our drive towards achieving early commercialisation of this very exciting discovery. We look forward to welcoming interested parties to the home of graphene where they will see how graphene is being developed and commercialised by 2-DTech through the combination of academic, scientific and commercial expertise."

 

For further information, please visit 2-DTech's new corporate website: http://2-dtech.com

 

- Ends -

 

For further information:

Versarien Plc

Neill Ricketts, Chief Executive Officer

Tel: +44 (0) 1594 888 622

Chris Leigh, Chief Financial Officer

www.versarien.com

 

Charles Stanley Securities

(Nominated Adviser and Broker)

Mark Taylor / Russell Cook

Tel: +44 (0) 20 7149 6000

 

Media Enquiries:

Abchurch Communications Limited

Henry Harrison-Topham / Jamie Hooper

Tel: +44 (0) 20 7398 7719

jamie.hooper@abchurch-group.com

www.abchurch-group.com

 

Notes to Editors

 

Versarien plc (AIM:VRS), is an advanced engineering materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries. Versarien has two wholly owned subsidiaries, Versarien Technologies Ltd and Total Carbide Ltd, and holds an 85% stake in 2-DTech Ltd.

 

Versarien Technologies Limited ("VTL")

VTL owns the exclusive rights to a patent-protected additive process for creating advanced micro-porous metals. Versarien primarily targets the thermal management industry exploiting the superb thermal properties exhibited by such materials. The company's lead product is VersarienCu, a micro-porous copper which on incorporation into liquid cooling systems, can improve efficiency by up to ten times. http://www.versarien.co.uk/

 

2-DTech Limited

On 1 May 2014, Versarien acquired 85% of the issued share capital of 2-DTech, a company closely aligned with The University of Manchester, the established home of graphene technology. 2-DTech specialises in the supply, characterisation and early stage development of graphene products. 2-DTech also works closely with industry and researchers to help turn scientific innovation into groundbreaking products. The acquisition will enable Versarien to apply its experience and expertise to commercialising graphene in the UK; demand for which is set to grow exponentially over the coming years. For further information about 2-DTech visit http://2-dtech.com/

 

Total Carbide Limited ("TC")

TC is one of the leading European manufacturers of sintered tungsten carbide, with a global customer base covering over forty different industries. It primarily manufactures arduous environment products for application in the oil and gas industry, along with multiple other industries. TC provides VTL with access to high volume manufacturing assets that have significantly expanded production of VersarienCu. http://www.totalcarbide.com/

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFSDLALVIIS
Date   Source Headline
4th Apr 20178:00 amRNSHolding(s) in Company
21st Mar 20177:00 amRNSCambridge Graphene Update
15th Mar 20179:43 amRNSHolding(s) in Company
9th Mar 20171:00 pmRNSHolding(s) in Company
6th Mar 20177:00 amRNSSuccessful Fundraising of £1.5 million
3rd Mar 20174:38 pmRNSFundraising of approximately £1 million
16th Feb 20177:00 amRNSNanene Distribution Agreement
8th Feb 20177:00 amRNSLaunch of Nanene
30th Jan 201710:04 amRNSHolding(s) in Company
19th Jan 20171:21 pmRNSAcquisition and Trading Update
19th Dec 20167:00 amRNSFurther Graphene Enhanced PAEK Plastics Agreement
14th Dec 201610:45 amRNSHolding(s) in Company
14th Dec 20167:00 amRNSGraphene enhanced PAEK Thermoplastics Agreement
29th Nov 20167:01 amRNSInterim Results
29th Nov 20167:00 amRNSSignificant Graphene Order
23rd Nov 20167:00 amRNSNotice of Results
9th Nov 201610:00 amRNSInvestor site visit presentations
31st Oct 20169:15 amRNSDebt for Equity Swap with UoM
27th Oct 20167:00 amRNSNew Healthcare Graphene Project
18th Oct 20167:00 amRNSInvestor Event
13th Oct 20167:00 amRNSCompletion of NGI composite project
3rd Oct 20167:00 amRNSAcquisition of AAC Cyroma
27th Sep 20161:38 pmRNSResult of AGM
1st Sep 201610:36 amRNSNotice of AGM
3rd Aug 20164:25 pmRNSHolding(s) in Company
2nd Aug 20169:53 amRNSHolding(s) in Company
1st Aug 20168:39 amRNSHolding(s) in Company
28th Jul 20162:01 pmRNSHolding(s) in Company
25th Jul 20167:00 amRNSFully subscribed placing to raise £1.1m
19th Jul 20167:00 amRNSFinal Results
23rd Jun 20167:00 amRNSGraphene Collaboration with CT Engineering
14th Jun 20167:00 amRNSGraphene Collaboration with Absolute Engineering
11th May 20167:00 amRNSGraphene enhanced carbon fibre collaboration
6th Apr 20167:00 amRNSTrading Update
31st Mar 20167:00 amRNS3D Printing with Graphene Trials
11th Mar 20167:00 amRNSResignation of Director
3rd Feb 20167:00 amRNSBoard Changes
11th Dec 20157:00 amRNSDirector Share Purchase
10th Dec 20157:00 amRNSInterim Results
1st Dec 20157:00 amRNSHolding(s) in Company
19th Nov 20157:00 amRNSNotice of Results
4th Nov 20157:00 amRNSChange of Adviser
12th Oct 201511:06 amRNSChange of Registered Office
24th Sep 201511:15 amRNSResult of AGM
21st Sep 20157:00 amRNSVersarien Attending SEC2SV in San Francisco
7th Sep 20157:00 amRNSGrant of US Graphene Patent
19th Aug 20159:53 amRNSAdditional Listing
18th Aug 20152:00 pmRNSPosting of Annual Report
21st Jul 20157:00 amRNSChange of Adviser
21st Jul 20157:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.